Meredith Cooper is an experienced healthcare professional with a strong background in oncology and clinical research. Currently serving as the Program Director of Strategic Initiatives and Program Director for the Hematologic Malignancies and Cellular Therapeutics Division at The University of Kansas Cancer Center since September 2015, Meredith Cooper manages oncology accreditations and collaborates with physicians and administrative leaders to uphold quality standards. Previous roles include Research Coordinator at the University of Kansas Medical Center, Clinical Data Coordinator at Quintiles, and Research Coordinator at Duke University Health System, where Meredith Cooper ensured compliance with regulatory requirements and managed research protocols. Meredith Cooper holds a Bachelor of Arts in Psychology from the University of Oklahoma, obtained in 2010.